<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2000/svg"><channel><title>MedTech on Silicon Polder</title><link>https://hugo.bytes.news/tags/medtech/</link><description>Recent content in MedTech on Silicon Polder</description><generator>Hugo -- gohugo.io</generator><language>en</language><lastBuildDate>Wed, 04 Feb 2026 09:53:55 +0000</lastBuildDate><atom:link href="https://hugo.bytes.news/tags/medtech/index.xml" rel="self" type="application/rss+xml"/><item><title>Future Tech Ventures Invests in SPCTR’s Instant Tumour Analysis Tech</title><link>https://hugo.bytes.news/posts/wednesday/c2deab2-medtech-oncology/</link><pubDate>Wed, 04 Feb 2026 09:53:55 +0000</pubDate><guid>https://hugo.bytes.news/posts/wednesday/c2deab2-medtech-oncology/</guid><description>&lt;p>&lt;em>Amsterdam, Wednesday 4 February 2026&lt;/em>
Future Tech Ventures has funded SPCTR to accelerate an AI device that creates real-time tissue fingerprints, enabling surgeons to assess tumour margins instantly and significantly reducing the need for repeat surgeries.&lt;/p></description></item><item><title>ShanX Medtech Secures €15 Million to Accelerate Rapid Antibiotic Treatment</title><link>https://hugo.bytes.news/posts/thursday/archive/e936729-medtech-antimicrobial-resistance/</link><pubDate>Thu, 15 Jan 2026 10:23:23 +0000</pubDate><guid>https://hugo.bytes.news/posts/thursday/archive/e936729-medtech-antimicrobial-resistance/</guid><description>&lt;p>&lt;em>Eindhoven, Thursday 15 January 2026&lt;/em>
Backed by Invest-NL and the EU, ShanX Medtech raised €15 million. Their technology cuts antibiotic diagnosis time from days to the same day, significantly bolstering the fight against resistance.&lt;/p></description></item></channel></rss>